Advertisement
Home 2016

Archives

Sustained clinical benefit has been observed in patients with heart failure with preserved left ventricular ejection fraction treated with an interatrial septal shunt device that allows shunting to reduce the left atrial pressure

AHA: Interatrial Shunt Effective at One Year in Heart Failure

0
Findings for patients with heart failure with preserved left ventricular ejection fraction
A fully implanted brain-computer interface has enabled a paralyzed woman with late-stage amyotrophic lateral sclerosis to communicate through brain signaling

Fully Implanted Brain-Computer Interface Shows Promise in ALS

0
Signals sent to hand emerge as typed message on a tablet computer, researchers report
For patients with inflammatory joint diseases

ACR: High Demand for CVD-Preventive Meds in IJD

0
High indication for medications, but initiation is infrequent in inflammatory joint disease cohort
In asymptomatic never smokers

AHA: Secondhand Tobacco Smoke Ups Atherosclerosis Risk

0
Extent of SHTS exposure linked to presence, extent of atherosclerosis in asymptomatic never smokers
Ticagrelor is not superior to clopidogrel for reduction of cardiovascular events in patients with peripheral artery disease

AHA: Ticagrelor Not Shown to Be Superior to Clopidogrel in PAD

0
No better for primary efficacy composite end point of cardiovascular death, myocardial infarction, stroke
The number of hospitalizations for heart failure has risen in the United States

AHA: Hospitalizations Up for Heart Failure in the United States

0
But length of stay and mortality are decreasing
A new injectable medication called inclisiran cuts low-density lipoprotein cholesterol by half or more

AHA: Inclisiran Twice Yearly May Effectively Control Cholesterol

0
Injectable medication is a next-level PCSK9 inhibitor
Exercising during and after cancer treatment is safe and improves quality of life

Cancer Patients Benefit From Exercise During, After Treatment

0
Studies show better physical function, quality of life for those who did strength training, aerobic activity
Combining statins with the PCSK9 inhibitor evolocumab can help reduce low-density lipoprotein cholesterol to previously unseen levels

AHA: Evolocumab Can Help Substantially Reduce LDL

0
Patients taking evolocumab and statins showed a reduction in arterial plaque volume
For patients with rheumatoid arthritis with interstitial lung disease

ACR: First-Line Rituximab May Improve Survival in RA-ILD

0
For RA patients with interstitial lung disease, rituximab linked to improved survival versus TNFi